Nurix Therapeutics, Inc. is a San Francisco based early clinical-stage biotechnology concern focused on leveraging its expertise in cellular protein modulation to develop therapies against ...
The fireside chat will be webcast live and may be accessed via a link in the Investors section of the Nurix website. The archived webcast will be available for 30 days after the event. About Nurix ...
SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback